HYG vs IBB

iShares iBoxx High Yield Corporate Bond ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.49% for HYG.
  • HYG pays a higher dividend yield (5.82%).

Side-by-side metrics

MetricHYGIBB
Expense ratio
Annual fee. Lower is better.
0.49%0.44%
Dividend yield
Trailing 12-month yield.
5.82%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$16.95B$7.95B
YTD return
1.41%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.670.74
P/E ratio
10.9823.72
Last price
$79.86$170.10
Inception
Issuer
iSharesiShares

HYG top holdings

Top holdings · HYG
XTSLABlackRock Cash Funds Treasury SL Agency1.38%
Sector breakdown · HYG
Real Estate0.4%
Utilities99.6%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About HYG

HYG (iShares iBoxx High Yield Corporate Bond ETF) is US high-yield corporate bonds. Managed by iShares, the fund carries $17.0B in assets under management, an expense ratio of 0.49%, a dividend yield of 5.82%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 0.4%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.